GNLX
Price
$2.50
Change
-$0.04 (-1.57%)
Updated
Apr 3 closing price
Capitalization
95.51M
34 days until earnings call
ZLDAF
Price
$0.30
Change
+$0.01 (+3.45%)
Updated
Mar 13 closing price
Capitalization
3.59M
Ad is loading...

GNLX vs ZLDAF

Header iconGNLX vs ZLDAF Comparison
Open Charts GNLX vs ZLDAFBanner chart's image
Genelux
Price$2.50
Change-$0.04 (-1.57%)
Volume$236.11K
Capitalization95.51M
Zelira Therapeutics
Price$0.30
Change+$0.01 (+3.45%)
Volume$117
Capitalization3.59M
GNLX vs ZLDAF Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. ZLDAF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Buy and ZLDAF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GNLX: $2.50 vs. ZLDAF: $0.30)
Brand notoriety: GNLX and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 109% vs. ZLDAF: 50%
Market capitalization -- GNLX: $95.51M vs. ZLDAF: $3.59M
GNLX [@Biotechnology] is valued at $95.51M. ZLDAF’s [@Biotechnology] market capitalization is $3.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, ZLDAF is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 3 TA indicator(s) are bullish.

  • GNLX’s TA Score: 3 bullish, 6 bearish.

Price Growth

GNLX (@Biotechnology) experienced а -17.49% price change this week, while ZLDAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

GNLX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNLX($95.5M) has a higher market cap than ZLDAF($3.59M). GNLX YTD gains are higher at: 5.932 vs. ZLDAF (-21.723). ZLDAF has higher annual earnings (EBITDA): -3.17M vs. GNLX (-26.78M). ZLDAF has higher revenues than GNLX: ZLDAF (40.9K) vs GNLX (8K).
GNLXZLDAFGNLX / ZLDAF
Capitalization95.5M3.59M2,659%
EBITDA-26.78M-3.17M845%
Gain YTD5.932-21.723-27%
P/E RatioN/AN/A-
Revenue8K40.9K20%
Total Cash34.1MN/A-
Total Debt2.04MN/A-
FUNDAMENTALS RATINGS
ZLDAF: Fundamental Ratings
ZLDAF
OUTLOOK RATING
1..100
35
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNLX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKHHY36.350.44
+1.23%
Heineken Holding N.V.
NHHHF0.02N/A
-0.46%
FUELPOSITIVE CORP.
AFMJF0.38N/A
-0.52%
Alphamin Resources Corp.
PPRUF205.17-4.83
-2.30%
Kering SA
PILBF0.93-0.05
-5.11%
PILBARA MINERALS LTD

GNLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with VSTM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-1.57%
VSTM - GNLX
46%
Loosely correlated
-2.40%
SNSE - GNLX
33%
Loosely correlated
-11.12%
HOOK - GNLX
28%
Poorly correlated
-7.22%
ZLDAF - GNLX
26%
Poorly correlated
N/A
GNMSF - GNLX
26%
Poorly correlated
+3.87%
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
VSTM - ZLDAF
47%
Loosely correlated
-2.40%
QLGN - ZLDAF
28%
Poorly correlated
-2.93%
GNLX - ZLDAF
25%
Poorly correlated
-1.57%
SNSE - ZLDAF
22%
Poorly correlated
-11.12%
KRON - ZLDAF
20%
Poorly correlated
-4.31%
More